Is erythropoietin safe in haemodialysis patients with multiple myeloma ?
Joint Authors
Husayn, Majdi
Mooij, Jacob
Roujouleh, Haytham M.
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 5, Issue 3 (30 Jun. 1994), pp.371-373, 3 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
1994-06-30
Country of Publication
Saudi Arabia
No. of Pages
3
Main Subjects
Topics
- Patients
- Neoplasms
- Multiple myeloma
- Hemodialysis
- Complications(Medicine)
- Kidney failure
- Recombinant erythropoietin
Abstract EN
The use of recombinant human erythropoietin (rHuEpo) for the treatment of anemia of end-stage renal disease (ESRD) is now well established.
There have also been reports about its use in treating the anemia of other diseases including multiple myeloma (MM).
Some concern about the usage of rHuEpo in patients with MM has been raised by studies reporting worsening of myeloma activity after starting this drug.
However, other studies have reported its safety in patients with MM.
We report here a patient on maintenance haemodialysis, not known to have MM who developed symptoms related to this disease four months after starting rHuEpo.
Although we might speculate that the onset of symptoms was coincidental and not causally related to rHuEpo, we recommend close monitoring of the disease activity in patients with MM receiving rHuEpo.
American Psychological Association (APA)
Husayn, Majdi& Mooij, Jacob& Roujouleh, Haytham M.. 1994. Is erythropoietin safe in haemodialysis patients with multiple myeloma ?. Saudi Journal of Kidney Diseases and Transplantation،Vol. 5, no. 3, pp.371-373.
https://search.emarefa.net/detail/BIM-214921
Modern Language Association (MLA)
Roujouleh, Haytham M.…[et al.]. Is erythropoietin safe in haemodialysis patients with multiple myeloma ?. Saudi Journal of Kidney Diseases and Transplantation Vol. 5, no. 3 (December 1994), pp.371-373.
https://search.emarefa.net/detail/BIM-214921
American Medical Association (AMA)
Husayn, Majdi& Mooij, Jacob& Roujouleh, Haytham M.. Is erythropoietin safe in haemodialysis patients with multiple myeloma ?. Saudi Journal of Kidney Diseases and Transplantation. 1994. Vol. 5, no. 3, pp.371-373.
https://search.emarefa.net/detail/BIM-214921
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 373
Record ID
BIM-214921